Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $78.5 million.

  • InspireMD's Liabilities and Shareholders Equity rose 5544.86% to $78.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.3 million, marking a year-over-year increase of 75.69%. This contributed to the annual value of $46.8 million for FY2024, which is 175.47% down from last year.
  • Per InspireMD's latest filing, its Liabilities and Shareholders Equity stood at $78.5 million for Q3 2025, which was up 5544.86% from $33.3 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Liabilities and Shareholders Equity registered a high of $78.5 million during Q3 2025, and its lowest value of $19.9 million during Q1 2023.
  • Over the past 5 years, InspireMD's median Liabilities and Shareholders Equity value was $42.6 million (recorded in 2021), while the average stood at $42.9 million.
  • In the last 5 years, InspireMD's Liabilities and Shareholders Equity surged by 55856.47% in 2021 and then tumbled by 4335.96% in 2023.
  • InspireMD's Liabilities and Shareholders Equity (Quarter) stood at $39.7 million in 2021, then crashed by 37.92% to $24.7 million in 2022, then skyrocketed by 93.25% to $47.6 million in 2023, then fell by 1.75% to $46.8 million in 2024, then skyrocketed by 67.65% to $78.5 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $78.5 million for Q3 2025, versus $33.3 million for Q2 2025 and $38.7 million for Q1 2025.